Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia

Medicina Clinica

Volumn 136, Issue 8, 2011, Pages 323-328

  Xicoy, Blanca ^a,b   Ribera, Josep María ^a,b   Miralles, Pilar ^c   La Cruz, José ^c   Oriol, Albert ^a,b   Valencia, Eulalia ^c   Morgades, Mireia ^a   Mahillo, Beatriz ^c   De La Torre, Julián ^c   Téllez, María Jesús ^c   Brunet, Salut ^b   Esteve, Jordi ^b   Hoelzer, Dieter ^d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b PETHEMA Group   (Spain)

^c GESIDA Group   (Spain)

^d GMALL Group   (Germany)

Author keywords

AIDS; Burkitt's leukemia; Burkitt's lymphoma; HIV infection; Specific chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINATE CALCIUM; HYDROCORTISONE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; TENIPOSIDE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; REMISSION; SHORT COURSE THERAPY; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; VINCRISTINE; YOUNG ADULT;

EID: 79952814433     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.07.025     Document Type: Article

References (20)

1. Gerecitano J, Straus DJ. Treatment of Burkitt lymphoma in adults. Expert Rev Anticancer Ther. 2006;6:373-81. (Pubitemid 44192919)
2. Hoelzer D, Hiddemann W, Baumann A, Döhner H, Dührsen U, Fietkau R, et al. High survival rate in adults Burkitt's lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement. Blood. 2007;110:159a.
3. Centers for Disease Control. 1993 revised classification system for HIV infection expands surveillance case definition for AIDS adolescents and adults: MMWR Recomm Rep. 1992; 41:1-19.
4. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;10:1419-32.
5. Mittelman F, editor. ISCN: an international System for human Cytogenetic Nomenclature. Basel: Karger; 1995.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457-81.
7. 2/E in the log-rank test for survival data or tumor incidence data. Biometrics. 1973;29:579-84.
8. Vaccher E, Spina M, di Gennaro G, Talamini R, Nasti G, Schioppa O, et al. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin's lymphoma. Cancer. 2001;91:155-63. (Pubitemid 32052626)
9. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med. 2006;336:1641-8.
10. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS clinical trials group protocol 142-low-dose versus standard dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 1998;16:3601-6. (Pubitemid 28506774)
11. Lim ST, Karim R, Bharat N, Tulpule A, Espina B, Levine AM. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol. 2005;23:4430-8. (Pubitemid 46207018)
12. Spina M, Simonelli C. Patients with HIV Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the active antiretroviral therapy. J Clin Oncol. 2005;23:8132-3. (Pubitemid 46657430)
13. Boue F, Gabarré J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F. Phase II trial of CHOP plus rituximab in patients with HIIV-associated non-Hodgkin's lymphoma. J Clin Oncol. 2006;24:4123-8. (Pubitemid 46622288)
14. Dunleavy K, Little R, Wayne AS, Grant N, Pittaluga E, Jaffe ES, et al. Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients. Blood. 2008;112:3606a.
15. Wang ES, Straus DJ, Teruya-Feldstein JT, Qin J, Portlock C, Moskowitz C, et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/ IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003;98:1196-205. (Pubitemid 37099904)
16. Cortés J, Thomas D, Rios A, Koller C, O'Brien S, Jeha S, et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer. 2002;94:1492-9. (Pubitemid 34212643)
17. Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, et al. Lack of influence of human imunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica. 2003;88:445-53.
18. Oriol A, Ribera JM, Brunet S, del Potro E, Abella E, Esteve J. Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica. 2005;90:990-2.
19. Oriol A, Ribera JM, Bergua J, Giménez Mesa E, Grande C, Esteve J, et al. High-dose chemotherapy and immunotherapy in adult Burkitt's lymphoma: comparison of results in human immunodeficiency virus-infected and non-infected patients. Cancer. 2008;113:117-25. (Pubitemid 351976392)
20. Hoffman C, Wolf E, Wyen C, Fatkenheuer G, Van Lunzen J, Stellbrink HJ. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective. Leuk Lymphoma. 2006;47:1872-80. (Pubitemid 44649772)